A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting

CAR T cells T lymphocytes aspergillosis cytokines immunotherapy mouse model

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
28 Feb 2024
Historique:
medline: 28 2 2024
pubmed: 28 2 2024
entrez: 28 2 2024
Statut: aheadofprint

Résumé

Invasive aspergillosis (IA) is a common and deadly mold infection in immunocompromised patients. As morbidity and mortality of IA are primarily driven by poor immune defense, adjunct immunotherapies, such as chimeric antigen receptor (CAR) T cells, are direly needed. Here, we propose a novel approach to generate

Identifiants

pubmed: 38415653
doi: 10.1128/mbio.03413-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0341323

Auteurs

Pappanaicken R Kumaresan (PR)

Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Sebastian Wurster (S)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Karishma Bavisi (K)

Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Thiago Aparecido da Silva (TA)

The International School of Pharmaceutical Sciences in Araraquara, Sao Paulo, Brazil.

Paul Hauser (P)

Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jordan Kinnitt (J)

Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Nathaniel D Albert (ND)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Uddalak Bharadwaj (U)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Sattva Neelapu (S)

Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Dimitrios P Kontoyiannis (DP)

Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Classifications MeSH